Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs Citius Pharmaceuticals, Inc. (CTXR)

aTyr Pharma, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($15.3M and $14.8M). Across the 11 metrics below, Citius Pharmaceuticals, Inc. leads on 7 and aTyr Pharma, Inc. on 4.

Valuation

Metric ATYR CTXR Biotechnology median
P/E n/m n/m 10.60
P/S 1.38 n/m 9.40
P/B 0.32 0.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.61 n/m 0.66
EV/Sales (3.49) n/m 9.02
Earnings yield (397.17%) (387.87%) (32.88%)
Free cash flow yield (355.97%) (242.31%) (23.13%)

Profitability

Metric ATYR CTXR Biotechnology median
Gross margin 1.72% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (64.51%) (51.96%)
Return on assets (70.97%) (34.29%) (46.06%)
Return on invested capital 0.00% (58.74%) 0.00%

Growth

Metric ATYR CTXR Biotechnology median
Revenue growth (TTM) 6.78% — 6.76%
EPS growth (last fiscal year) 7.54% 43.38% 29.88%
Revenue growth, 5-year CAGR (14.75%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR CTXR Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 5.12 0.84 4.97
Net debt to EBITDA 1.01 0.11 1.01

Dividend

Metric ATYR CTXR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATYR CTXR Biotechnology median
Market cap 14.78m 15.31m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack